The German and U.S. health systems resemble each other in some ways, but not so much when it comes to prescription drug pricing: Germany's use of reference pricing and price negotiation keeps drug costs well below those in the U.S. In a new issue brief, James C. Robinson of the University of California, Berkeley, and colleagues explain how Germany does it, and why some version of its approach might work in this country.